Expression of two novel eph-related receptor protein tyrosine kinases in mammary gland development and carcinogenesis
about
Comparative analysis of the gene-dense ACHE/TFR2 region on human chromosome 7q22 with the orthologous region on mouse chromosome 5Molecular cloning of a ligand for the EPH-related receptor protein-tyrosine kinase HtkAn Eph receptor regulates integrin activity through R-RasDifferential regulation of EphA2 in normal and malignant cellsEphB6-null mutation results in compromised T cell functionRegulation of mammary gland branching morphogenesis by EphA2 receptor tyrosine kinaseOverexpression of erythropoietin-producing hepatocyte receptor B4 and ephrin-B2 is associated with estrogen receptor expression in endometrial adenocarcinoma.Embryonic stem cells express multiple Eph-subfamily receptor tyrosine kinases.Internalizing cancer antibodies from phage libraries selected on tumor cells and yeast-displayed tumor antigensHigh EphA2 protein expression in renal cell carcinoma is associated with a poor disease outcome.Clinical and biological impact of EphA2 overexpression and angiogenesis in endometrial cancerEphB6 crosslinking results in costimulation of T cellsEph/ephrin signaling in epithelial development and homeostasisEphA2 overexpression is associated with lack of hormone receptor expression and poor outcome in endometrial cancer.EPHA2 is a mediator of vemurafenib resistance and a novel therapeutic target in melanoma.EphA2 is a critical oncogene in melanoma.The receptor tyrosine kinase EphA2 is a direct target gene of hypermethylated in cancer 1 (HIC1).Expression of EphA2 and EphrinA-1 in vulvar carcinomas and its relation to prognosisEph receptor and ephrin function in breast, gut, and skin epithelia.The multifaceted roles of Eph/ephrin signaling in breast cancer.Expressions of EphA2 and EphrinA-1 in early squamous cell cervical carcinomas and their relation to prognosis.The EphA2 receptor and ephrinA1 ligand in solid tumors: function and therapeutic targeting.Eph receptors in breast cancer: roles in tumor promotion and tumor suppression.EphA2 overexpression promotes ovarian cancer growth.EphA2 immunoconjugate as molecularly targeted chemotherapy for ovarian carcinomaDual targeting of EphA2 and FAK in ovarian carcinoma.Therapeutic synergy between microRNA and siRNA in ovarian cancer treatment.Roles of EphA2 in Development and Disease.Membrane-mediated regulation of vascular identity.Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth.Purification of a ligand for the EPH-like receptor HEK using a biosensor-based affinity detection approachBiological significance of EPHA2 expression in neuroblastoma.High-level expression of EphA2 receptor tyrosine kinase in prostatic intraepithelial neoplasia.The SAM domain inhibits EphA2 interactions in the plasma membrane.
P2860
Q24290904-672BE40A-816D-4A4E-9A40-CF35D142F009Q24563938-81B8363E-097F-4FEB-AE8E-B92C340F54E5Q24643888-25F47586-15C9-42DB-8FFE-632F9DEA3BBCQ24684095-CEF8776E-22AB-4020-92C3-27D88B41DD1DQ28513533-35CF5393-19BF-40E0-AE0A-A6FDBE00C6AEQ28585639-2237EDA7-7BB3-4C2A-B557-783434115AE8Q33599430-9CDDECDE-0A9F-48A8-A585-3E161DFCE7EBQ33604421-E3EF42FB-F48F-4B09-A6A1-8C0B8F7ED1EAQ33695432-AE0D7DAB-4FBA-4052-84B0-B018BAEA416CQ33844126-EF76E89B-9A27-4255-B8C6-8139BE621259Q34616549-10AC61B6-8224-406F-9F37-ADEB343383D1Q34785859-58512564-E51C-4D9A-B046-A5AEBF3ACA90Q35026768-9E3772E6-377C-478F-87A4-2A4BF34D8438Q35114341-147501F5-876A-4F39-90BA-83C7749A5D76Q35163679-78227256-1A8A-4EE2-8027-10459DAEC00BQ35218960-CD3137C1-C754-4A65-99F4-6DADB015870AQ35773939-737F46AC-15AE-49B4-BBCB-98590B6B5839Q36054843-6C686A2A-2769-45A0-97A3-3C78262AD25AQ36125059-DA5DBF64-9BED-4E2E-BC23-1B1A17851C00Q36402719-A47F7C51-DEC8-4120-90FA-CC5577B87CF7Q36713605-38399FFB-7942-443C-B16E-694AC982C3F2Q36950556-470C91A6-A1D2-40D1-878E-0208F6020413Q37131357-A2E7926C-5B7F-4071-9BF7-C23F2556D102Q37251068-FFB13CCE-EC5C-460A-ACDF-DBE53F1C58EEQ37329160-AE617FBF-7FAE-448A-8C3A-DCD4A9C58F5EQ37357254-CD92816B-A0E6-4F3D-BD24-45409B8ADA12Q37373640-EFCCB1CC-EA5D-4033-BFA3-E558508486E7Q37584993-4B080D2C-03FA-4315-B7A1-46C123E76DCFQ37643632-F33882D5-8FFE-4CF2-BB70-5443BC6B3F61Q37682093-F1DDDE19-FB0E-41C6-BD3D-FB3F0E489524Q37696894-611BAF22-9D0B-4F12-ADFF-73C6147009C0Q39227009-F07876F8-7FD9-4F75-A662-E88C20F04BF0Q42071638-DA1771A5-A59B-4EF5-8631-E8A52AEF3A3DQ51123807-39E0773B-8A7C-4AAA-AD77-C5575FF9F58C
P2860
Expression of two novel eph-related receptor protein tyrosine kinases in mammary gland development and carcinogenesis
description
1994 nî lūn-bûn
@nan
1994 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Expression of two novel eph-re ...... development and carcinogenesis
@ast
Expression of two novel eph-re ...... development and carcinogenesis
@en
Expression of two novel eph-re ...... development and carcinogenesis
@nl
type
label
Expression of two novel eph-re ...... development and carcinogenesis
@ast
Expression of two novel eph-re ...... development and carcinogenesis
@en
Expression of two novel eph-re ...... development and carcinogenesis
@nl
prefLabel
Expression of two novel eph-re ...... development and carcinogenesis
@ast
Expression of two novel eph-re ...... development and carcinogenesis
@en
Expression of two novel eph-re ...... development and carcinogenesis
@nl
P2093
P1433
P1476
Expression of two novel eph-re ...... development and carcinogenesis
@en
P2093
A C Andres
A Ziemiecki
D Albrecht
R J Blaschke
P304
P407
P577
1994-05-01T00:00:00Z